Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 14Uveal Melanoma 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Basal Cell 2Urologic Neoplasms 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1Tertiary Lymphoid Structures 1Spinocerebellar Degenerations 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Microsatellite Instability 1Male Urogenital Diseases 1Locally Advanced Melanoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Gastroesophageal Cancer 1

Interventions

Nivolumab 5palbociclib 2Radiosurgery 2Protons 2Proton Therapy 2Pemetrexed 2Ipilimumab 2Imatinib Mesylate 2tazemetostat 1relatlimab 1pembrolizumab 1nilotinib 1camrelizumab 1apatinib 1Zoledronic Acid 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Photochemotherapy 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Melphalan 1Mastectomy, Segmental 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Disulfides 1Dihematoporphyrin Ether 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chordoma × relatlimab × Clear all
NCT03623854 2024-04-16

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Jonsson Comprehensive Cancer Center

Phase 2 Completed
10 enrolled
Sarcoma

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡